anonymous
Guest
anonymous
Guest
Hope it’s a good one, but it won’t work. The constant changing of IC every quarter and the abysmal plans they keep concocting are pushing everyone to look.
It's decent enough to keep top performers.
Hope it’s a good one, but it won’t work. The constant changing of IC every quarter and the abysmal plans they keep concocting are pushing everyone to look.
Retention bonus being rolled out by end of the week!
How many Ophthalmology SAMs are left from the original 43? Probably less than 5 in less than 4 years. Great leadership!It’s not a really a retention bonus. You’ll see tomorrow.
It’s not a really a retention bonus. You’ll see tomorrow.
What were you expecting? Do you expect anyone to pay out big money to keep a sales force that is severely underperforming in every possible metric including sales? The OBU is why Amgen is here they see a sales force so poorly run and performing but yet huge potential.
The goals in this division are not aligned with rare disease! They are skewed towards high volume territories many that are putting in false PEFs and have been for quite some time. Many are making less in bonus now that when they first started and are at or over goal!What were you expecting? Do you expect anyone to pay out big money to keep a sales force that is severely underperforming in every possible metric including sales? The OBU is why Amgen is here they see a sales force so poorly run and performing but yet huge potential.
The goals in this division are not aligned with rare disease! They are skewed towards high volume territories many that are putting in false PEFs and have been for quite some time. Many are making less in bonus now that when they first started and are at or over goal!
IC is a mess. That retention bonus is a mess.
SAMs don’t have control over starts and how quickly they happen, stop tying bonus to others performance. We can only control what happens in our own territories.
Maybe Tepezza started off hot but when you’re the only Rx treatment there’s a bunch of untreated patients to fill the funnel, now that it’s been out for a while the amount in the funnel is far less.
The check the box metrics, forced programs are ridiculous and very primary care.
The entire OBU is a train wreck and it starts with Richard and Eric.
ProgramsThe problem is we have an entire team with little to no rare disease experience. And they are incapable of going out and filling the "funnel". If you aren't doing programs then you clearly don't know how to fill the "funnel". Your division needs to be micromanaged.
Programs!? LOL OkThe problem is we have an entire team with little to no rare disease experience. And they are incapable of going out and filling the "funnel". If you aren't doing programs then you clearly don't know how to fill the "funnel". Your division needs to be micromanaged.
Programs!? LOL Ok
This response tells the rest of us pretty much what everyone already figured. Your sales team has no idea what they are doing. Over your head.
These rep fights are adorable.I do not sell Tepezza but I have sold 2 rare Disease products and speaker programs are not the make or break factor for success.
These rep fights are adorable.
you should see them go at it at Panera over who gets the last Asiago bagel for their rare disease food drop.
extensions flying, makeup smeared, LV bags swinging…..and that’s just the guys.
shut the fuck upwith such a "woke" company culture its becoming hard to tell if its a guy or girl. Thank God for the pronouns in the email signatures
shut the fuck up
shut the fuck upTry not to dip your skirt in the urinal princess.
What fun!Oh great more leadership from GSK!
shut the fuck up